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Introduction 
 
In spite of recent advances in our understanding of the pathophysiology and treatment of 
idiopathic pulmonary fibrosis (IPF), clinical assessment remains challenging due to a paucity 
of clinically sensitive biomarkers. We present a longitudinal pilot study to assess the potential 
role of magnetic resonance imaging (MRI) techniques in assessing gas diffusion and perfusion 
in IPF. 
 
Methods 
 
Nineteen patients with IPF, but without echocardiographic evidence of pulmonary 
hypertension were recruited from a tertiary centre (mean age 71.4 years). All underwent 
magnetic resonance spectroscopy with inhaled hyperpolarised xenon (129Xe) MRI. During 
breath-hold maneuvers, a high-resolution MR spectroscopy sequence acquired MR spectra of 
129Xe dissolved in the pulmonary tissue and plasma (TP) and red blood cell (RBC) 
compartments. Integrals of RBC and TP spectral peaks were expressed as the ratio RBC:TP. 
Fifteen participants returned at six months, and twelve returned at 12-months. Five 
participants died before completing follow-up. In addition, twelve participants agreed to 
undergo Dynamic Contrast-Enhanced MRI (DCE-MRI) with gadolinium at baseline. Eight 
returned at 12-months. Parametric maps of bolus transit time across the lungs were produced 
and a mean transit time across all pixels is reported (MTT). Pulmonary function tests were 
performed at each visit, including forced vital capacity (FVC) and diffusing capacity of the 
lungs for carbon monoxide (DLCO). 
 
 
Results 
 
129Xe RBC:TP correlated with both DLCO (r=0.65; p=0.003) and MTT (r=-0.70; 0.008). This 
relationship with DLCO was preserved at six (r=0.77; p=0.001) and twelve months (r=0.67; 
p=0.018). However, while DLCO did not significantly change over 12-months (-0.5% median 
change; p=0.791) both RBC:TP (-0.08 change; p=0.002) and MTT (1.69s change; p=0.031) 
demonstrated whole-lung changes. RBC:TP and MTT changes were not significantly 
correlated (p=0.091) On parametric maps, transit time was increased in basal and peripheral 
regions of lung tissue (Figure) and progressed in these areas over time. 
 
Conclusion 
 
Hyperpolarised 129Xe spectroscopy and DCE-MRI have potential to probe diffusion and 
perfusion pathophysiology in IPF and are potentially more sensitive to change than existing 
whole-lung markers of gas exchange. Regional lung mapping is likely to yield highly sensitive 
metrics, possibly for patient enrichment or detection of treatment response in early 
intervention studies. 
 
 
 
 
 
Figure Legend: 
Coronal computed tomography slice (A) and parametric pulmonary transit time map derived 
from dynamic contrast-enhanced magnetic resonance imaging (B). Flow of contrast is slower 
among regions of reticulation and honeycombing. 
 
